Moh. Asadullah Hasan Al Asy'arie
Faculty of Law, Universitas Diponegoro, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Traditional Medicine Innovation Policy: Between the Protection of Traditional Knowledge, Genetic Resources, and Intellectual Property Kholis Roisah; Moh. Asadullah Hasan Al Asy'arie; Rahayu Rahayu; Shofiy Zulfah
Legality : Jurnal Ilmiah Hukum Vol. 34 No. 2 (2026): September
Publisher : Faculty of Law, University of Muhammadiyah Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22219/ljih.v34i2.43917

Abstract

This study analyses how innovation in traditional medicine can be strengthened through the convergence of policies on traditional knowledge protection, genetic resources governance, and intellectual property rights to support national independence in drug availability. Using a qualitative normative design, this research examines statutory regulations, international instruments, and institutional practices relevant to traditional medicine, biogenetic conservation, and intellectual property management. The methodological approach includes doctrinal legal analysis, conceptual analysis, and policy evaluation to map regulatory overlaps, gaps, and strategic opportunities for integration. The study finds that Indonesia possesses vast biodiversity and rich traditional medicinal knowledge that remain underutilised in pharmaceutical innovation. Regulatory frameworks governing traditional knowledge, genetic resource access, and intellectual property work in parallel but lack harmony, resulting in problems related to standardisation, benefit-sharing, research authorisation, and commercialisation. Findings also indicate that strengthening scientific validation, through standardised extraction, preclinical and clinical testing, and quality assurance, significantly increases the potential of traditional medicines to advance into standardised herbal medicines and phytopharmaceuticals. The study concludes that policy convergence is essential to ensure equitable protection of traditional knowledge, sustainable use of genetic resources, and effective commercialisation of research outputs. An integrated framework is required to support national drug independence, enhance bioeconomic value creation, and promote fair benefit distribution for indigenous and local communities.
BPI Danantara as A Hybrid Entity in Indonesian Economic Law Paramita Prananingtyas; Moh. Asadullah Hasan Al Asy'arie; Ayup Suran Ningsih; Hazlina Shaik Md Noor Alam
Jurnal Suara Hukum Vol. 8 No. 2 (2026): Jurnal Suara Hukum
Publisher : Universitas Negeri Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26740/jsh.v8n2.p466-499

Abstract

Danantara, Indonesia’s newly established sovereign wealth investment institution, is designed to consolidate and optimize state assets while operating with corporate efficiency. Its hybrid public–corporate character makes the governance question urgent: it must enable investment discretion without weakening public accountability, transparency, and anti-corruption safeguards. This article employs a normative juridical method using secondary legal materials, combining statutory and conceptual approaches. The study examines the principal legislation and implementing regulations establishing Danantara and situates them within doctrines on sovereign wealth fund governance, good corporate governance, and the business judgment rule. The analysis shows that the framework grants wide managerial powers and a corporate-style governance structure, yet leaves accountability vulnerabilities, including unclear public-official status of managers, discretionary oversight provisions, and exposure to political influence over business decisions. The article concludes that Danantara’s legitimacy and performance depend on mandatory oversight rules, arm’s-length decision-making, transparent investment audit trails for major transactions, robust conflict-of-interest controls, independent audit access, and merit-based appointments, so prudent risk-taking is protected while impunity is prevented.